---
title: "Spyre Therapeutics Plunges; Why Analysts Aren't Sweating"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297076229.md"
description: "On Wednesday, Spyre Therapeutics experienced a decline in its stock value due to the failure of its rheumatoid arthritis treatment in midstage trials. The impact was significant enough to raise concerns among investors and analysts. The unsuccessful testing has caused a considerable drop in the company's stock price, leading to a negative outlook on its future prospects in the market. Despite this setback, the analysts are not overly worried about the company's overall performance, suggesting that there might be potential for recovery or alternative strategies in the future."
datetime: "2026-08-26T17:35:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297076229.md)
  - [en](https://longbridge.com/en/news/297076229.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297076229.md)
generator: "portal-rs"
---

# Spyre Therapeutics Plunges; Why Analysts Aren't Sweating

On Wednesday, Spyre Therapeutics experienced a decline in its stock value due to the failure of its rheumatoid arthritis treatment in midstage trials. The impact was significant enough to raise concerns among investors and analysts. The unsuccessful testing has caused a considerable drop in the company's stock price, leading to a negative outlook on its future prospects in the market. Despite this setback, the analysts are not overly worried about the company's overall performance, suggesting that there might be potential for recovery or alternative strategies in the future.

### Related Stocks

- [SYRE.US](https://longbridge.com/en/quote/SYRE.US.md)

## Related News & Research

- [Insider Selling: Spyre Therapeutics (NASDAQ:SYRE) Insider Sells $36,000.00 in Stock](https://longbridge.com/en/news/297984230.md)
- [Spyre Therapeutics CEO Turtle Cameron disposes of 15,000 common shares worth $1.31 million](https://longbridge.com/en/news/297975740.md)
- [Top Executive’s Bold Stock Move Shakes Up Super Group](https://longbridge.com/en/news/297724882.md)
- [Major Investor Quietly Trims Stake in Anteris Technologies Global Corp.](https://longbridge.com/en/news/297723139.md)
- [Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)](https://longbridge.com/en/news/297408646.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**